Publication | Closed Access

Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer

OncologyMedicineIrinotecan PharmacokineticsBronchial NeoplasmAnti-cancer AgentCancer TreatmentLung CancerPharmacologyRadiation OncologyPharmacokineticsDrug DiscoveryPharmacogenetic Prediction